Skip to main content

Table 2 Physical assessment variables among non-COPD and COPD patients

From: Clinical impact of prevalence and severity of COPD on the decision-making process for therapeutic management of lung cancer patients

 

All cases (n = 270)

Non-COPD (n = 123)

COPD (n = 147)

p value

BMI (kg/m 2 ) a

22.1 (2.8)

22.0 (2.8)

22.2 (2.9)

0.749

spirometric variables

    

%VC a

105.9 (20.6)

104.8 (20.8)

106.7 (20.5)

0.520

FEV1 (ml) a

2062 (610)

2302 (555)

1861 (583)

0.0001 #

FEV1/FVC a

67.3 (12.6)

77.8 (6.3)

58.9 (10.3)

0.0001 #

%FEV1 predicted a

98.2 (25.7)

109.4 (21.1)

88.9 (25.4)

0.0001 #

%IC a

85.9 (19.5)

83.6 (17.8)

87.9 (20.6)

0.111

chest CT finding

    

emphysema

30.4 (82)

20.3 (25)

38.8 (57)

0.001 #

  1. n indicates number.
  2. aData are shown as mean (SD).
  3. All other data are shown as% (numbers).
  4. #p < 0.05.
  5. BMI: body mass index; VC: vital capacity; FEV1: forced expiratory volume in 1 second; FVC: forced vital capacity; IC: inspiratory capacity; GOLD: the Global Initiative for Chronic Obstructive Lung Disease.